ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188 /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black;...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
SCHEDULE 13G Amendment No. 1 ADVENTRX PHARMACEUTICALS INC Common Stock Cusip #00764X202 Cusip #00764X202 Item 1: Reporting Person - FMR...
ADVENTRX Announces Appointment of Chief Financial Officer /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...
ADVENTRX To Present At The 6th Annual OneMedForum Emerging Company Finance Conference On January 8 /* Style Definitions...
File No. 812-14041 UNITED STATES OF AMERICA BEFORE THE U.S. SECURITIES AND EXCHANGE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads